Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 August 2022 | Story Edzani Nephalela and Coreen Steenkamp | Photo Francois van Vuuren
Academic Leadership Programme
The new cohort of the Academic Leadership Programme.

Educational leaders serve a significant administrative, management, and leadership function in higher education. A departmental chair’s role differs fundamentally from other leadership contexts, based on the momentous transition from being an academic by profession to providing leadership at departmental level.
The Academic Leadership Programme (APL) was launched by the University of the Free State (UFS) Centre for Teaching and Learning (CTL) to equip academics for various managerial positions. Faculty deans propose candidates for this programme; the second cohort has been chosen as the first is nearing completion. 
The first workshop commenced with an engagement with the Rector and Vice-Chancellor of the UFS, Prof Francis Petersen, and the Vice-Rector: Academic, Dr Engela van Staden, who both shared strategic academic leadership perspectives during the orientation and welcoming of the APL. 
Such reflections highlighted the expectations of being an educator, the complexity, and the critical role of departmental chairs within higher education institutions. Academic leaders are thus expected to establish firm leadership within their departments, facilitate intellectual development, manage administrative duties, and strive toward resilient learning and teaching environments. 
“The position of departmental chairs remains critical for any higher education institution, as they provide leadership in advancing the discipline, teaching students, producing quality graduates, and serving the professional community,” said Prof Francois Strydom, Senior Director: Centre for Teaching and Learning.
Research confirms that most academics succeed in these roles without formal leadership training, yet the expectation of developing or having certain leadership qualities or management competencies must fulfil the various functions of such a position. 


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept